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Purpose: In order to determine the drug release profile of an ensemble of aspirin crystals or 
microcapsules from its particle distribution a mathematical model that considered the 
individual release characteristics of the component single particles was developed.  The 
model assumed that under sink conditions the release from individual (component) particles 
would be independent of each other and hence simply additive. 
Method: The release parameters, mt = the amount of drug released in time t, m∞ = the 
maximum release and t∞ = the time to attain it were determined for each single particle by 
simulation using previously derived mathematical models.  To obtain the cumulative release 
curve for the ensemble the individual releases were summed up at each time scale and for 
the various time intervals.  Values of m∞ and t∞ for the ensemble were obtained from the 
simulated cumulative curves.  The release profiles of the ensembles were also determined 
experimentally and their m∞ and t∞ values deduced from the release curves. 
Results: The observed cumulative curves of the ensembles compared favourably with the 
simulated data.  The % difference in the observed and the simulated m∞ and t∞ values of the 
ensembles was within ± 20%, which indicated that the modelling was valid.  
Conclusion: The study showed that the release profile of an ensemble can be determined 
from its particle distribution which has application in controlled release studies. 
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Introduction 
 
Water insoluble polymers such as the 
acrylate methacrylates have been frequently 
applied on drug microparticles to obtain 
controlled release1, 2. The resulting micro-
capsules are invariably inhomogeneous with 
respect to either the distribution of particle 
size, shape, nature of the wall (coating) 
material and/or wall thickness. A poly-
disperse system is therefore an ensemble of 
such inhomogeneously distributed particles.  
The release profile of an ensemble is 
dependent on the release characteristic of 
the individual (component) particles, and 
hence the particle distribution which may 
therefore be predetermined by computer 
simulation to optimize drug release3. 
 
The important parameters which define the 
release profile of a microencapsulated drug 
are the rate order kinetic, the diffusion 
coefficient, the maximum release, m∞ and 
the time to attain it, t∞. Whereas the 
ensemble of microcapsules invariably 
displays a first order rate kinetic the single 
(component) microcapsules display a zero 
order rate profile3-7.  The individual particles 
were found to be inhomogeneous in the 
distribution of the release parameters, m∞ 
and t∞. Consequently summation of the 
individual releases from the single particles 
will give a cumulative release curve of he 
first order type, which was confirmed 
experimentally3, 4. The individual releases 
are additive only under a sink condition such 
that the release from the individual particles 
are independent of each other.  This finding 
provides a basis for predicting the release 
profile of an ensemble of a given particle 
distribution.  In the previous studies3, 4, the 
release data on several single particles of 
various sizes and weights were first 
determined empirically and the data 
subsequently used to simulate the release 
profiles of the ensembles, which is tedious.  
In the first part of this report we showed that 
the release profiles of the single particles 
could be simulated applying certain derived 
mathematical models8.  Also the previous 
study3 was modelistic in design as one 
particle each of different sizes and weights 
were randomly selected to constitute the 
ensemble.  In the present study the model 
was applied to an actual polydisperse 




Details of the derivation of the mathematical 
models for the simulation of the drug release 
profiles of the single particles of aspirin of an 
orthorhombic shape have been presented 
elsewhere in a recent publication8.  The 
model allowed the estimation of the 
parameters m∞, t∞ and mt (the amount 
released at time intervals, t) from each 
particle in the distribution.  In the case of the 
single crystals only the simulated amount of 
drug that would be released at the transition 
point from zero to first order release was 
designated as m1 and the time to attain it as 
t1
8.  The data are used here to simulate drug 
release from the ensembles based on the 
model: 





)(iit mnM t                ……… (1)  (1) 
where Mt is the cumulative release from the 
ensemble in time t, ni is the number of 
particles each of size i distributed between 
the 1st and the Nth term which in the system 
studied were 0.3 mm and 1.4 mm 
respectively (i.e. the particle size range), mi(t) 
is the individual release from each particle in 
time, t. The maximum value of mi(t) is 
predetermined as the calculated m∞ of that 
particle achieved in time, t∞. This model 
assumes that under sink conditions the 
release from individual particles in the 
ensemble would be independent of each 
other and therefore additive. 
 
An aspect which was not considered in the 
first part of this study8 is the development of 
mathematical models for the simulation of 
the release profiles of single microcapsules 
at different wall thicknesses.  The published 
values of m∞ and t∞ relate to single 
microcapsules of wall thickness, 11 µm8.  
Values of these parameters at other wall 
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thicknesses e.g. 27 µm were estimated in 
the present study from the modified Fick 
equation, applicable to drug release from 
microcapsules9, thus: 
       t
L
K
m =                       ……… (2)  
where K is the proportionality constant for 
mass transfer through a wall barrier of 
thickness, L; m is the mass transferred in 
time, t.  At the point of maximum release m = 
m∞ and t = t∞ in equation 2.  Thus the 
maximum release m∞(1) and m∞(2) of two 
microcapsules of same core weight but of 
different wall thicknesses, L1 and L2 
respectively, can be compared by the ratios: 











∞                  ……… (3)  
and similarly, 












∞ =                ……… (4)  
These expressions are based on the inverse 
relationship between m∞ and L and the direct 
relationship between m∞ and t∞, (equation 2) 
since the m∞ and t∞ values of microcapsules 
of wall thickness 11 µm (represented by L1) 
were already known 8 the corresponding 
values for microcapsules of same core 
weight but of wall thickness 27 µm 
(represented by L2) were easily computed.  
The simulated values were used to compute 
the release profile of the ensembles. 
 
Materials and Methods 
 
Aspirin crystals (Synopharm Ltd., Germany) 
were selected as the core material primarily 
because of the ease of their micro-
encpsulation by spray coating methods, thus 
obviating the need for preliminary 
pelletization, as would be the case with a 
fine powder. The particles were mainly 
orthorhombic with size range 0.3 to 1.4 mm; 
the most frequent size was 0.7 to 0.8 mm 
(frequency, 70%)8. The frequency – size 
distribution in a sample of the aspirin crystals 
(100 mg) is given in Table 1.  Acetone 
(analar grade, BDH Poole, England) was 
used as solvent in the preparation of the 
polymeric coating fluid, while 
dibutylphthalate (reagent grade, BDH) was 




The polymer films were applied on the 
aspirin crystals by a spray coating method, 
details of the technique have been described 
elsewhere8.  Resulting microcapsules were 
of coating thickness 11 and 27 µm.  The 
cores (i.e. the aspirin crystals) varied in size, 
0.3 to 1.4 mm. 
 
Determination of drug release 
 
The procedure for single particles has been 
described earlier8. To determine release 
from the ensembles, a sample of the crystals 
or the microcapsules (100 mg) was placed in 
1000 ml water in a conical flask and 
stoppered. The flask was mounted on a 
shaker bath which was agitated 50 rev. min–1 
and maintained at a temp. 37 °C. At pre-
determined time intervals 3 min (crystals) or 
30 min (microcapsules) samples (2ml) were 
withdrawn from the leaching fluid with a 
pipette fitted with a cotton wool plug. The 
samples were analyzed with a spectro-
photometer (Hitachi U – 1100, Tokyo, Japan) 
at λmax 267 nm.  Each experiment was 
carried out in triplicate and the mean results 
reported.  The cumulative amounts of drug 
released were plotted against time and from 
the curves the values of m∞ and t∞ were 
obtained. 
 
Simulation of drug release 
 
A computer program, GW-BASIC (Microsoft 
Corporation, USA) was employed in the 
simulation. The computation was based on 
equation 2 which was built into the program. 
Values of the release parameters, mt, m1, t1, 
m∞, t∞, of the single particles which are 
needed for the simulation of the cumulative 
release of the ensembles have been 
published earlier8, except the data on single 
microcapsules of wall thickness of 27 µm 
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which are presented in the present report in 
Figure 2b. 
 
To obtain the simulated release from 
particles of each size fraction, the individual 
release at a particular time interval from a 
single particle of a given size was multiplied 
by the number of particles of that size 
represented by nimi(t) in equation 1. These 
were in turn summed up at each time scale 
and for the various time intervals to obtain 
the cumulative release curves.  The system 
simulated was the accidental distribution of 
particles in a 100 mg samples (Table 1).  For 
the ensembles of the crystals the results are 
presented in Table 1.  The cumulative 
release data were plotted versus time and 
from the curves the values of m∞ and t∞ were 
obtained. 
 
Determination of the rate order of release 
 
Most drug delivery systems release their 
drug content by either zero or first order rate 
kinetic.  Consequently in the present study, 
the cumulative release data on the 
ensembles were analyzed on the basis of 
zero or first order rate kinetic.  The release 
was considered to follow a particular kinetic 
if the correlation coefficient was ≥0.90. 
Table 1a: Simulated cumulative release data for ensembles of the crystals  
Simulated release (µg) from particles of each size fraction (nimi) at various 







0 3 6 9 10 12 13 14 15 17 
0.3 27 0 42 56 57 57 57 57 57 57 57 
0.4 27 0 74 74 134   136 136 136 136 136 136 
0.5 67 0 291 291 647 653 662 662 662 662 662 
0.6 281 0 178 178 4621 4694 4778 4806 4806 4806 4806 
0.7 1058 0 908 908 27010 27645 28386 2858 28756 28756 28756 
0.8 884 0 9915 991 29744 33049 34454 35001 35346 35832 35832 
0.9 254 0 3624 3624 1087 12077 13810 14077 14346 14496 14669 
1.0 80 0 1409 1409 4227 4697 5636 5971 6112 6209 632 
1.1 30 0 6 6 1919 2132 2558 2772 2980 3052 3151 
1.2 17 0 424 424 1271 1413 1695 1836 1977 2150 2235 
1.3 12 0 348 348 1043 1159 1390 1506 1622 1738 1972 
1.4 7 0 230 230 691 766 922 998 1075 1152 1306 
Cumulative  2743 
release (mg) 
0 28 28 82 88 94 96 98 99 100 
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Validation of the models 
 
The models employed in the simulation were 
considered valid if the observed results were 
in the same order of magnitude as the 
simulated data.  The data were compared by 
means of a proportional difference given by: 
   100×−
S
ES
          ……… (5)  
where S = simulated data and E = the 
empirical or observed data.   
 
The parameters compared were the 
correlation coefficient, r, for the rate order of 
release, m∞ and t∞ which define the release 
profiles of the ensembles.  The proportional 
difference is a measure of the % deviation of 
the empirical from the simulated data. The 
results are presented in Table 2. The 
simulation was considered valid if the % 
deviation of the observed from the simulated 




Simulated release data on the single 
particles 
 
The release curves of the single crystals 
already published earlier8 are represented 
here (Figure 1), as the data would contribute 
to the understanding of how the release data 
in Table 1 were generated.  As noted in the 
previous report the curves fitted into an initial 
zero order followed by a first order release 
profile.  The linear portion of the plot 
represents the zero order flux and the curved 
Table 1b: Simulated cumulative release data for ensembles of the crystals contd. 
Simulated release (µg) from particles of each size fraction (nimi) at various 







18 19 20 21 22 23 24 27 30 
0.3 27 57 57 57 57 57 57 57 57 57 
0.4 27 136 136 136 136 136 136 136 136 136 
0.5 67 662 662 662 662 662 662 662 662 662 
0.6 281 4806 4806 4806 4806 4806 4806 4806 4806 4806 
0.7 1058 28756 28756 28756 28756 28756 28756 28756 28756 28756 
0.8 884 35832 35832 35832 35832 35832 35832 35832 35832 35832 
0.9 254 14674 14674 14674 14674 14674 14674 14674 14674 14674 
1.0 80 6356 6356 6356 6356 6356 6356 6356 6356 6356 
1.1 30 3156 3173 3172 3173 3173 3173 3173 3172 3172 
1.2 17 2259 2275 2288 2288 2288 2288 2288 2288 2288 
1.3 12 1958 1989 2011 2025 2036 2036 2036 2036 2036 
1.4 7 1365 1398 1420 1435 1445 1453 1453 1453 1453 
Cumulative  2743 
release (mg) 
100 100 100 100 100 100 100 100 100 
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Table 2: Comparison of the release parameters (m∞ and t∞) 
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Figure 1:  Simulated release profiles of hypothetical 
single crystals of various particle sizes (mm) 
represents the zero order flux and the curved 
portion the first order phase. 
 
The release data on the single 
microcapsules are presented 
in Figure 2.  The data 
generally fitted into a zero 
order release profile.  An 
increase in wall thickness from 
11 to 27 µm brought about a 
profound decrease in the 
maximum release, m∞ while 
the time to attain it, t∞ 
increased considerably 
(compare Figures 2A and 2B).  
These parameters also varied with core 
weight or size.  This means that the 
point of maximum release (the extent 
and duration) can be controlled by 
variation in the microcapsule core 
weight and/or the wall thickness. 
 
Simulated cumulative release 
profiles of the ensembles 
 
The releases from particles of each size 
fraction of the crystals (taking into 
account the release from each particle 
(Figure 1) and the number of particles 
of each size) are presented in Table 1, 
from which the cumulative curve of the 
crystals was obtained; the curves for 
the two sets of ensembles of the 
microcapsules were similarly deduced.  
The cumulative curves of the three sets 
of ensembles are shown in Figure 3. 
The points for maximum release (m∞, 
and t∞) were obtained from these 
curves; the values are given in Table 2. 
The release profiles (Figure 3) 
generally fitted into an initial zero order 
flux followed by a first order release, as 
was the case with the single crystals 
(Figure 1). 
 
The evidence which suggests this 
profile for the ensembles is that the 
linear correlation coefficient was 
generally ≥ 0.95 when the data were 
analyzed on the basis of an initial zero 
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Figure 3: Simulated cumulative release curves of 
ensembles of the crystals (υ ), and the micro-capsules 
of wall thickness: 11µm (π ), and 27µm (ϒ ). 
Figure 2: Simulated release profiles of single microcapsules of different wall thicknesses, A (11 µ), 


























Figure 4: Empirical cumulative release profiles of 
the 3 sets of ensembles-crystals (↓ ), and the 
microcapsules of wall thickness 11um (ϒ ), and 
27um ( ). 
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oerder plot (up to 90% release) followed by 
first order plot for the remaining portion up to 
the maximum release.  The correlation index 
fell below 0.8 when the data were analyzed 
entirely either as a zero order or as a first 
order plot. 
 
Empirical release profiles of the 
ensembles: The curves are presented in 
Figure 4.  The profiles are in many respects 
similar to the simulated curves for the 
ensembles (Figure 3).  The observed m∞ and 
t∞ values are presented in Table 2; they 
differed from the simulated values by a 
maximum of ± 22% (Table 2).  The 
simulation predicted a decrease in m∞ from 
48 to 18 µg and an increase in t∞ from 150 to 
340 min during increase in wall thickness 
from 11 to 27 µm.  The actual change in m∞ 
was 58 to 22 µg and in t∞, 120 to 280 min.  
These results lend credence to the models 




Interpretation of the release kinetics 
 
The simulation revealed that the single 
crystals would give an initial zero order 
release (about 90% of initial particle weight) 
followed by a first order profile while the 
single microcapsules would display a total 
zero order release.  The release parameters 
m∞ and t∞ were inhomogeneously distributed 
among the particles due to individual 
differences in particle weight and/or wall 
thickness (in the case of the microcapsules).  
Based on the previous observation3, 4 that 
such inhomogeneous distribution in the m∞ 
and t∞ values would result in a first order 
release profile for the ensembles, this 
release profile for the ensembles studied 
here was expected.  Instead what emerged 
was an initial zero order followed terminally 
by a first order profile. Unlike previous 
system3, 4 where the different particles were 
in the ensemble in equal number, the 
present system was characterized by a 
dominant size fraction both in terms of their 
number and weight in the particle size 
distribution (Table 1).  The smallest and the 
largest particles were very few compared 
with the mid size (0.7 – 0.8 mm) particles.  
Number of these mid size particles was up to 
2000 out of a total of about 2700 particles.  
The data in Table 1 also show that this size 
fraction contributed predominantly to the 
overall release from the ensemble. Moreover 
the point for maximal release (m∞ and t∞) of 
this size fraction was close to that of the 
ensemble.  As a result of this dominance, the 
release kinetic from the single crystals will be 
similar to that of their ensembles.  The effect 
in the microcapsules would be that their 
ensembles would display a first order 
release profile only after the release from the 
dominant size fraction has attained a 
maximum.  Hence, the initial zero order 
release followed by a first order profile 
observed for the ensembles of the 
microcapsules. 
 
Influence of particle distribution on the 
release profile from the ensembles  
 
From the results of this study the main factor 
that determined the release profile of the 
ensemble was the particle distribution.  The 
evidence is that the release profiles of the 
ensembles which were deduced from their 
particle distribution were comparable to the 
empirical release profiles.  The particles may 
be distributed with regards to particle size, 
shape and/or wall thickness, thus giving a 
flexible approach for optimizing drug release 
by predetermining the particle distribution in 
simulation studies.  The selection of the 
particles will be based on their individual m∞ 
and t∞ values (Figures 1 and 2). For instance 
a distribution which is predetermined to 
contain equal number of particles, say 884 of 
size, 0.8 mm each of the single crystals 
(Table 1) and of the single microcapsules of 
wall thickness 11 µm (Figure 2A) will display 
a cumulative curve of the type in Figure 5, 
which is characterized by a prompt release 
from the crystal and a sustained release 
from the microcapsule fractions. The 
maximum release of the ensemble and the 
time to attain it can be predetermined as 
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follows. The maximum release from the 
crystal particles is given by:  
 
n(0.8)m∞(0.8) = 884 x 41µg = 36244µg  
 
where m∞(0.8) is the maximum release of a 
single crystal particle (Figure 1).  Similarly 
the maximum release from all the single 
microcapsules will be 884 × 19 µg = 16596 
µg, 19 µg being the maximum release of a 
single microcapsule (Figure 2A)).  Hence the 
maximum release of the ensemble is given 
by summation 36244 + 16596 µg = 52840 
µg.  Its t∞ of the ensemble will be determined 
by the t∞ of the microcapsule (the slow 
release fraction) which is 140 min (Figure 2).  
Unlike the m∞ the t∞ of a particle is 





This study has shown that the release profile 
of a polydisperse multiparticulate system can 
be reliably deduced from its particle 
distribution and the release profiles of the 
individual (component) particles in the 
distribution. Hence, the particle distribution 
may be predetermined in simulation studies 
to optimize drug release.  The release 
parameters (m∞ and t∞) of the single particles 
can be theoretically derived which provides a 
rationale basis for the selection of the 
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Figure 5: A plot of cumulative release from a 
predetermined distribution of aspirin crystals and 
microcapsules of 0.8 mm 
